Lars Fruergaard Jorgensen
Lars Fruergaard Jorgensen is the CEO of Novo Nordisk, a Danish pharmaceutical company renowned for its innovative treatments for diabetes and obesity. Under his leadership, the company has focused on expanding its portfolio of obesity medications, including the highly successful Wegovy. Jorgensen has emphasized the strong demand for obesity treatments, despite market fluctuations and competition from other pharmaceutical companies.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Slovenia:
Lars Fruergaard Jorgensen is the CEO of Novo who mentioned that his company would feel the short-term effects of tariffs.
5
Bulgaria:
Lars Fruergaard Jorgensen is the CEO of the Danish company Novo Nordisk.
8
Bulgaria:
Lars Fruergaard Jorgensen is the CEO of Novo Nordisk and commented on the strong demand for obesity treatment drugs.
8